My IDSA Contact Us
IDSA NewsPrint-Friendly Newsletter
Forward to a Friend
Search Back Issues
 
Education & Training Resources Practice Guidelines Journals & Publications Policy & Advocacy Meetings About IDSA
Dec. 2012/Jan. 2013
Top Stories
New Guideline on Prosthetic Joint Infection Now Online

A new IDSA practice guideline for the diagnosis and management of prosthetic joint infection (PJI) is available online and appeared in the Jan. 1 issue of Clinical Infectious Diseases.

The guideline is intended for infectious disease specialists, orthopedists, and internists who care for patients with PJI. An essential component of this care is a strong collaboration between medical and surgical specialists (e.g., orthopedic surgeons and ID specialists). Consequently, the guideline identifies the preferred method of diagnosis for patients with PJI, such as preoperative evaluation and intraoperative testing, and addresses the necessity for surgical intervention and prolonged courses of intravenous or oral antimicrobial therapy.

Several recommendations for appropriate treatment of debridement, retention of prosthesis, and resection arthroplasty are provided. In addition, recommendations for preferred treatment regimens (e.g., dosage of rifampin following debridement) and information leading to the reduction of morbidity, mortality, and costs associated with PJI are also included. “The guideline authors hope these recommendations will benefit patient care and provide a valuable resource for clinicians caring for patients with prosthetic joint infection,” said lead author Douglas R. Osmon, MD, associate professor of medicine in the division of infectious diseases at the Mayo Clinic in Rochester, Minn.

The guideline acknowledges that not all medical institutions will have the necessary resources to implement all of the outlined recommendations and that proper referrals to specialty centers may be needed. Also, several research gaps are identified, such as in the epidemiology, management, and prevention of PJI.

The guideline is available as a pocket-sized quick-reference edition. Visit the practice guidelines section of the IDSA website for additional guidelines and related resources, including a new Guidelines Discussion Forum, which allows members and others to comment on recently published IDSA practice guidelines.
How useful is this article?

< Previous Article | Next Article >

Post a comment

Your name:

Your comment:


Patient Care and Science
New Guideline Pocketcards: Prosthetic Joint Infection, Streptococcal Pharyngitis
Drug Approvals, Recalls, Adverse Events Update
Clinical Practice Management
Help Boost ID Participation in Physician Compensation Survey
“Ask the Coder” Your Tough Coding Questions
Global ID
FDA Approval of TB Drug a Milestone, With Caveats
U.S. TB Drug Shortages Highlight Global Gaps
A Doctor’s Path Takes Him Back to Africa
Policy and Advocacy
Congress Averts Large Cuts in Medicare, Federal Funding—For Now
IDSA Calls for Stronger Recommendation on HCV Screening
Which Pathogens Should Qualify for R&D Incentives?
Balanced Approach Needed on H5N1 Select Agent Proposal
IDSA Comments on Guidance for Developing Abdominal Infection Drugs
Your Colleagues
Check Out “My IDSA” for Latest Member News
Education & Resources
Celebrate 50 Years of IDSA and the Annual Meeting
Top Stories
From the President:
A Delicate Balance on Dual Use Research of Concern
New Guideline on Prosthetic Joint Infection Now Online
EIN Update: MDR Gram-Negative Osteomyelitis Infections
IDSA Journal Club

IDSA | 1300 Wilson Blvd., Suite 300 | Arlington, VA 22209 | Phone: (703) 299-0200
To ensure delivery, please add 'info@idsociety.org' to your email address book or Safe Sender List.
If you are still having problems receiving our communications,
see our white-listing page for more details.